Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 248,107 | 251,272 | 131,843 | 163,885 | 53,231 |
| Receivables | 3,272 | N/A | N/A | N/A | 726 |
| Inventories | 194 | 0 | N/A | N/A | N/A |
| Other current assets | 12,096 | 3,029 | 0 | 0 | 0 |
| TOTAL | $268,930 | $261,865 | $141,799 | $167,650 | $55,011 |
| Non-Current Assets | |||||
| PPE Net | 668 | 478 | 597 | 187 | 178 |
| Intangibles | 17,260 | 17,260 | 17,260 | 17,260 | 17,260 |
| Other Non-Current Assets | 15,193 | 6,004 | 5,413 | 369 | 775 |
| TOTAL | $33,121 | $23,742 | $23,270 | $17,816 | $18,213 |
| Total Assets | $302,051 | $285,607 | $165,069 | $185,466 | $73,224 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,516 | 5,283 | 4,785 | 4,352 | 1,350 |
| Accrued Expenses | 35,951 | 19,051 | 13,486 | 8,165 | 6,105 |
| Other current liabilities | 2,880 | 948 | 653 | 308 | 474 |
| TOTAL | $45,347 | $25,282 | $18,924 | $12,825 | $7,929 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,004 | 9,621 | 0 | N/A | 42 |
| Other Non-Current Liabilities | 71,092 | 69,473 | 52,984 | 50,004 | 0 |
| TOTAL | $81,096 | $79,094 | $52,984 | $50,004 | $42 |
| Total Liabilities | $126,443 | $104,376 | $71,908 | $62,829 | $7,971 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,362 | 19,114 | 14,946 | 12,026 | 11,897 |
| Common Shares | 193 | 191 | 127 | 120 | 89 |
| Retained earnings | -300,850 | -266,820 | -159,187 | -96,470 | -50,359 |
| Other shareholders' equity | 875 | -8,612 | 6,452 | 4,293 | 1,001 |
| TOTAL | $175,608 | $181,231 | $93,161 | $122,637 | $65,253 |
| Total Liabilities And Equity | $302,051 | $285,607 | $165,069 | $185,466 | $73,224 |